Jazz Pharmaceuticals
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Jazz Pharmaceuticals's balance sheet done over the years? Its assets were worth $11,393,359,000 last year, which is more than in the previous period. 67% of Jazz Pharmaceuticals’s total assets is currently financed by debt. Its liabilities reached the amount of $7,656,362,000, which means an decrease by -1% compared compared to last year.
Debt to Assets
| 2014 | 3338955000 | 1.96B | 58.93% |
|---|---|---|---|
| 2015 | 3359663000 | 1.76B | 52.42% |
| 2016 | 4800227000 | 2.92B | 60.89% |
| 2017 | 5123672000 | 2.41B | 47.05% |
| 2018 | 5203491000 | 2.44B | 47.01% |
| 2019 | 5538897000 | 2.42B | 43.83% |
| 2020 | 6535901000 | 2.87B | 44.01% |
| 2021 | 12298639000 | 8.33B | 67.76% |
| 2022 | 10835255000 | 7.74B | 71.52% |
| 2023 | 11393359000 | 7.65B | 67.2% |
JAZZ Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 1.50B | 881.48M | 591.44M | 1.05B | 637.34M | 309.62M | 386.03M | 365.96M | 988.78M | 684.04M |
Short term investments | 120M | 30M | 0 | 1.07B | 440M | 515M | 215M | 60M | 0 | 0 |
Net receivables | 705.79M | 651.49M | 563.36M | 396.49M | 355.98M | 263.83M | 224.12M | 234.24M | 209.68M | 186.37M |
Inventory | 597.03M | 714.06M | 1.07B | 95.39M | 78.60M | 52.95M | 43.24M | 34.05M | 19.45M | 30.03M |
Other current assets | 506.28M | 267.19M | 252.39M | 152.49M | 78.89M | 67.57M | 99.86M | 29.31M | 39.74M | 115.39M |
Total current assets | 3.43B | 2.60B | 2.61B | 2.83B | 1.63B | 1.23B | 968.27M | 748.06M | 1.25B | 1.01B |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 234.98M | 301.37M | 343.42M | 257.10M | 270.89M | 200.35M | 170.08M | 107.49M | 85.57M | 58.36M |
Goodwill | 1.75B | 1.69B | 1.82B | 958.30M | 920.01M | 927.63M | 947.53M | 893.81M | 657.13M | 702.71M |
Intangible assets | 5.41B | 5.79B | 7.15B | 2.19B | 2.44B | 2.73B | 2.97B | 3.01B | 1.18B | 1.43B |
Long term investments | 4.7M | 5.5M | 12.02M | 5.23M | 7.42M | 9.58M | 7.67M | 9.73M | 23.26M | 33.17M |
Other non-current assets | 69.24M | 58.89M | 40.81M | 25.72M | 47.91M | 42.69M | 16.41M | 14.06M | 27.54M | 15.93M |
Total non-current assets | 7.95B | 8.22B | 9.68B | 3.69B | 3.90B | 3.96B | 4.15B | 4.05B | 2.10B | 2.32B |
Total assets | 11.39B | 10.83B | 12.29B | 6.53B | 5.53B | 5.20B | 5.12B | 4.80B | 3.35B | 3.33B |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 463K | 2.09M | 2.54M | 4.72M | 5.41M | 8.61M | 1.12M | 1.37M | 1.13M |
Short term debt | 624.40M | 31M | 31M | 246.32M | 33.38M | 33.38M | 40.60M | 36.09M | 37.58M | 9.42M |
Total current liabilities | 1.53B | 933.19M | 809.30M | 653.74M | 364.49M | 345.48M | 293.94M | 257.40M | 226.64M | 216.80M |
| Non-current liabilities: | ||||||||||
Long term debt | 5.16B | 5.76B | 6.10B | 1.98B | 1.72B | 1.56B | 1.54B | 1.99B | 1.15B | 1.33B |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 104.75M | 106.81M | 116.99M | 101.14M | 109.37M | 218.87M | 176.60M | 112.61M | 69.25M | 38.39M |
Total non-current liabilities | 6.11B | 6.81B | 7.52B | 2.22B | 2.06B | 2.10B | 2.11B | 2.66B | 1.53B | 1.75B |
Total liabilities | 7.65B | 7.74B | 8.33B | 2.87B | 2.42B | 2.44B | 2.41B | 2.92B | 1.76B | 1.96B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |